Skip to content

Hepatitis C virus impairs brain function in HIV-positive people

TB treatment and HBV: risk factors for liver toxicity in South Africans on antiretroviral therapy

Hepatic steatosis widespread among HIV/HCV coinfected patients in France

Retreating HIV-positive patients chronically infected with HCV rarely works

Prolonging hepatitis C therapy by an additional 20 weeks has few benefits

Tenofovir provides an effective long-term treatment for hepatitis B in HIV-positive patients

No single drug associated with cryptogenic liver disease

Abacavir associated with a poorer response to HCV therapy

Only 25% of HIV-positive patients with acute HCV accepting HCV therapy